India is growing in importance as a hub for biopharmaceutical manufacturing, particularly in the context of the proposed Biosecure Act in the United States. The Act aims to restrict U.S. biotech companies from working with Chinese firms, potentially driving more business towards Indian contract development and manufacturing organizations (CDMOs). A...
India’s Biocon Acquires Eywa Pharma of New Jersey
Bangalore headquartered biopharmaceutical company, Biocon Ltd., announced that its step-down, wholly-owned subsidiary, Biocon Generics Inc., has acquired Eywa Pharma Inc.’s oral solid dosage manufacturing facility, located in Cranbury, New Jersey, effective 1st September, 2023. The facility was acquired for a total consideration $7.7 million. As part of the acquisition, the...
Aurobindo Subsidiary, Evive Biotech to Commercialize Ryzneuta in U.S.
New Jersey-based Acrotech Biopharma, a wholly-owned subsidiary of Aurobindo Pharma USA Inc., entered into a licensing agreement with Evive Biotech a subsidiary of China's Yifan Pharmaceutical Company Ltd., to commercialize Ryzneuta in the U.S. market. The product, a novel dimeric G-CSF long-acting fusion protein without pegylation, is presently under late-stage...
NJ-Based Amneal Pharma Launches Commercial Operations in India
Amneal Pharmaceuticals, is gearing up for new launches and is on a hiring spree. The company says it is also open for possible acquisitions to boost its India portfolio. The drug maker has plans to bring differentiated products based on novel drug delivery systems, biosimilars and specialty drugs from its...
India's Team Indus to Design Equipment for NASA's Moon Lander
NASA is following up its Apollo mission to the Moon with its new mission Artemis in 2024, and has selected three commercial Moon landing service providers that will deliver science and technology payloads under Commercial Lunar Payload Services as part of the Artemis program. The three consortia that will design...
BD India To Certify Hospitals in Patient Safety
Franklin Lakes, New Jersey-based Becton, Dickinson (BD) in partnership with the Oakbrook, Illinois-headquartered Joint Commission International (JCI) launched a new patient safety program for hospitals, called Preventing Risks of Infections and Medication Errors in Intraveneous Therapy (PRIME) in India. PRIME is a programmatic approach toward patient safety which will be...